MA26507A1 - Compositions pharmaceutiques d'aerosol - Google Patents

Compositions pharmaceutiques d'aerosol

Info

Publication number
MA26507A1
MA26507A1 MA25113A MA25113A MA26507A1 MA 26507 A1 MA26507 A1 MA 26507A1 MA 25113 A MA25113 A MA 25113A MA 25113 A MA25113 A MA 25113A MA 26507 A1 MA26507 A1 MA 26507A1
Authority
MA
Morocco
Prior art keywords
pharmaceutical compositions
aerosol pharmaceutical
aerosol
compositions
pharmaceutical
Prior art date
Application number
MA25113A
Other languages
English (en)
Inventor
David Lewis
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
On Davis Ganderton
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA26507(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MA26507A1 publication Critical patent/MA26507A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
MA25113A 1997-06-13 1998-06-12 Compositions pharmaceutiques d'aerosol MA26507A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (1)

Publication Number Publication Date
MA26507A1 true MA26507A1 (fr) 2004-12-20

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25113A MA26507A1 (fr) 1997-06-13 1998-06-12 Compositions pharmaceutiques d'aerosol

Country Status (45)

Country Link
EP (2) EP1219293A3 (fr)
JP (1) JP4380802B2 (fr)
KR (1) KR100546239B1 (fr)
CN (1) CN1138532C (fr)
AR (1) AR012977A1 (fr)
AT (1) ATE222751T1 (fr)
AU (1) AU729966B2 (fr)
BG (1) BG63906B1 (fr)
BR (1) BR9805993B1 (fr)
CA (1) CA2263445C (fr)
CO (1) CO4940408A1 (fr)
CZ (1) CZ295521B6 (fr)
DE (1) DE69807420T3 (fr)
DK (1) DK0920302T4 (fr)
DZ (1) DZ2516A1 (fr)
EA (1) EA001259B1 (fr)
EE (1) EE03664B1 (fr)
ES (1) ES2182351T5 (fr)
GB (1) GB2326334A (fr)
GE (1) GEP20012462B (fr)
HK (1) HK1022271A1 (fr)
HR (1) HRP980317B1 (fr)
HU (1) HU228487B1 (fr)
ID (1) ID21491A (fr)
IL (1) IL128484A (fr)
IN (1) IN189317B (fr)
IS (1) IS2435B (fr)
IT (1) IT1293803B1 (fr)
MA (1) MA26507A1 (fr)
ME (2) MEP44008A (fr)
MY (1) MY119074A (fr)
NO (1) NO327775B1 (fr)
NZ (1) NZ334149A (fr)
PL (1) PL193721B1 (fr)
PT (1) PT920302E (fr)
RS (1) RS51274B (fr)
SA (1) SA98190821B1 (fr)
SI (1) SI0920302T2 (fr)
SK (1) SK284430B6 (fr)
TN (1) TNSN98087A1 (fr)
TR (1) TR199900288T1 (fr)
TW (1) TW555570B (fr)
UA (1) UA70289C2 (fr)
WO (1) WO1998056349A1 (fr)
ZA (1) ZA985136B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
AU7026800A (en) 1999-09-11 2001-04-17 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
ES2234694T3 (es) * 1999-11-23 2005-07-01 Glaxo Group Limited Formulaciones farmaceuticas de salmeterol.
DE60019167T2 (de) * 1999-12-24 2006-05-11 Glaxo Group Ltd., Greenford Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
CN1213732C (zh) * 2000-05-22 2005-08-10 奇斯药制品公司 用于加压计量吸入器的稳定药用溶液制剂
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
DK1273292T3 (da) 2001-07-02 2004-10-04 Chiesi Farma Spa Optimeret tobramycinformulering til aerosoldannelse
EP1340492A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique
EP1340503A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formule d'une solution pour aerosol contenant des dérivés d'esters de 3,17 estratrien pour administration pulmonale
PL209212B1 (pl) 2002-03-01 2011-08-31 Chiesi Farma Spa Superdrobny preparat formoterolu
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
ES2275778T3 (es) * 2002-06-06 2007-06-16 Chiesi Farmaceutici S.P.A. Solubilizacion de farmacos en propulsores de hfa mediante emulsiones.
JP2006516545A (ja) * 2003-02-04 2006-07-06 クリサリス テクノロジーズ インコーポレイテッド パーフルオロカーボン及びハイドロフルオロカーボン製剤及びその製法及び使用法
US7914770B2 (en) * 2003-03-20 2011-03-29 Boehringer Ingelheim Pharmaceuticals, Inc. Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
EP1915985A1 (fr) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation pour une dose mesurée utilisant des hydro-fluoro-alcanes en tant que propulseurs
EP1595531A1 (fr) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression
JP5209963B2 (ja) 2004-07-02 2013-06-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 噴霧剤としてｔｇ２２７ｅａ又はｔｇ１３４ａを含有するエアロゾル懸濁製剤
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
US20110105449A1 (en) * 2007-11-07 2011-05-05 Astrazeneca R&D Dry powder formulations comprising ascorbic acid derivates
WO2012032010A1 (fr) * 2010-09-06 2012-03-15 Chiesi Farmaceutici S.P.A. Aérosol-doseur et sa méthode d'utilisation
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
US20170189329A1 (en) 2014-07-29 2017-07-06 3M Innovative Properties Company Method of preparing a pharmaceutical composition
WO2017167737A1 (fr) 2016-03-31 2017-10-05 Chiesi Farmaceutici S.P.A. Dispositif d'inhalation d'aérosol
IL265349B2 (en) * 2016-09-19 2023-03-01 Mexichem Fluor Sa De Cv Pharmaceutical composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293929C (fr) † 1986-03-10 1992-01-07 Kurt Burghart Composition pharmaceutique contenant de la nifedipine
EP0259383B1 (fr) † 1986-03-10 1991-01-23 Kurt Dr. Burghart Produit pharmaceutique et son procede de preparation
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
DK0553298T3 (da) † 1990-10-18 1995-04-18 Minnesota Mining & Mfg Aerosolformulering omfattende beclomethason-17,21-dipropionat
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ES2269582T3 (es) † 1991-06-10 2007-04-01 Schering Corporation Formulaciones en aerosol sin clorofluorocarbonos.
DE69208660T2 (de) † 1991-06-10 1996-07-11 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DK0616525T3 (da) * 1991-12-12 1996-01-08 Glaxo Group Ltd Medikamenter
DE69232034T2 (de) * 1991-12-18 2002-06-06 Minnesota Mining & Mfg Aerosolzusammensetzungen für Arzneimittelsuspensionen
PL177078B1 (pl) * 1992-12-09 1999-09-30 Boehringer Ingelheim Pharma Preparaty roztworów aerozolowych
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
WO1995031182A1 (fr) † 1994-05-13 1995-11-23 Aradigm Corporation Formulation en aerosol contenant un narcotique
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
AU3453897A (en) * 1996-07-08 1998-02-02 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
WO1998024420A1 (fr) † 1996-12-04 1998-06-11 Bioglan Ireland (R & D) Limited Compositions pharmaceutiques et leurs dispositifs d'administration
ES2178817T3 (es) † 1997-02-05 2003-01-01 Jago Res Ag Formulaciones medicinales de aerosol.

Also Published As

Publication number Publication date
WO1998056349A1 (fr) 1998-12-17
GB9712434D0 (en) 1997-08-13
SI0920302T2 (sl) 2006-10-31
ITMI971798A1 (it) 1999-01-28
GEP20012462B (en) 2001-06-25
PL331531A1 (en) 1999-07-19
UA70289C2 (uk) 2004-10-15
CZ46299A3 (cs) 1999-07-14
EE9900055A (et) 1999-08-16
IT1293803B1 (it) 1999-03-10
JP2000516965A (ja) 2000-12-19
CZ295521B6 (cs) 2005-08-17
HK1022271A1 (en) 2000-08-04
ATE222751T1 (de) 2002-09-15
EP0920302B1 (fr) 2002-08-28
AU8626298A (en) 1998-12-30
EP1219293A2 (fr) 2002-07-03
BR9805993A (pt) 1999-08-31
SK284430B6 (sk) 2005-04-01
EA199900201A1 (ru) 1999-06-24
HRP980317A2 (en) 1999-04-30
TNSN98087A1 (fr) 2005-03-15
RS51274B (sr) 2010-12-31
DZ2516A1 (fr) 2004-11-08
EP0920302A1 (fr) 1999-06-09
IN189317B (fr) 2003-02-08
IL128484A0 (en) 2000-01-31
CN1229355A (zh) 1999-09-22
AU729966B2 (en) 2001-02-15
NO990594L (no) 1999-04-13
TW555570B (en) 2003-10-01
GB2326334A (en) 1998-12-23
SA98190821B1 (ar) 2006-11-19
PT920302E (pt) 2002-11-29
EE03664B1 (et) 2002-04-15
IS2435B (is) 2008-10-15
DK0920302T3 (da) 2002-12-23
BG103221A (en) 1999-09-30
HUP0001339A2 (hu) 2000-09-28
SI0920302T1 (en) 2002-12-31
ES2182351T5 (es) 2007-03-16
DE69807420T3 (de) 2006-11-16
DK0920302T4 (da) 2006-10-09
MEP44008A (en) 2011-02-10
ID21491A (id) 1999-06-17
ZA985136B (en) 1999-01-07
CA2263445A1 (fr) 1998-12-17
ME00333B (me) 2011-02-10
NO327775B1 (no) 2009-09-21
CA2263445C (fr) 2008-09-09
EA001259B1 (ru) 2000-12-25
NO990594D0 (no) 1999-02-09
KR100546239B1 (ko) 2006-01-26
MY119074A (en) 2005-03-31
HU228487B1 (en) 2013-03-28
IL128484A (en) 2004-09-27
IS4974A (is) 1999-02-11
CO4940408A1 (es) 2000-07-24
JP4380802B2 (ja) 2009-12-09
DE69807420D1 (de) 2002-10-02
HRP980317B1 (en) 2002-06-30
DE69807420T2 (de) 2003-05-08
CN1138532C (zh) 2004-02-18
BR9805993B1 (pt) 2009-05-05
NZ334149A (en) 2000-07-28
ES2182351T3 (es) 2003-03-01
YU6999A (sh) 2000-03-21
AR012977A1 (es) 2000-11-22
SK17699A3 (en) 1999-07-12
EP1219293A3 (fr) 2003-05-28
HUP0001339A3 (en) 2000-10-30
KR20000068171A (ko) 2000-11-25
EP0920302B2 (fr) 2006-06-21
BG63906B1 (bg) 2003-06-30
TR199900288T1 (xx) 1999-09-21
PL193721B1 (pl) 2007-03-30

Similar Documents

Publication Publication Date Title
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
DE69530325D1 (de) Aerosol-arzneiformulierungen
IS4706A (is) Lyfjasamsetningar
ID24654A (id) Formulasi farmasi omeprazola
BR9610153A (pt) Formulações farmacêuticas
DK1073417T3 (da) Farmaceutisk aerosolformulering
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
ID18352A (id) Komposisi-komposisi farmasi
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
EE9900440A (et) Farmatseutilised kompositsioonid
ITMI941169A0 (it) Formulazioni farmaceutiche
MA26531A1 (fr) Composition pharmaceutique
EE200000330A (et) Farmatseutilised kompositsioonid
PT941100E (pt) Composicoes farmaceuticas
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973280A (fi) Farmaseuttinen koostumus
FI962738A0 (fi) Farmaseuttiset koostumukset
BR9605777A (pt) Composição farmacêutica
NO994436L (no) Farmasöytiske sammensetninger
BR9605131A (pt) Composição farmacêutica
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
HUP0004274A3 (en) Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof
BR1100755A (pt) composição farmacêutica
BR1101151A (pt) Compostos e composição farmacêutica
ITMI972373A0 (it) Composizioni farmaceutiche ad attivita'analgesica